Perth-based Alexium International Group has been awarded a $US200,000 ($195,286) contract by the US Air Force Research Laboratory to demonstrate its Cleanshell CB treatments for chemical and biological protection suits.
This contract follows two other purchase orders by the US Army over the last year.
An estimated 200,000 chemical and biological protection suits are purchased annually by the US military.
Alexium’s Cleanshell CB repellency treatment used to treatment of the outershell fabric of chemical protection suits.
The Cleanshell treatment has been optimised to provide water and oil repellency, but has also shown dramatically increased repellency of chemical warfare agent.
The USAF contract was awarded to further demonstrate Cleanshell CB on a range of different fabric types and to develop additional performance capabilities. The work will include testing against a range of live chemicals, such as soman and mustard nerve agents.
"We see this project as an important catalyst to more rapidly qualify and field our protective treatments – which will position the company for larger procurement opportunities,” Alexium chief operating officer Stefan Susta said.
This defence contract follows the recently announced Duro contract in the commercial sector for fire retardant nylon treatments.
Shares in Alexium were unchanged at 0.075 cents.